SS
Samantha Semenkow Citigroup Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
30
Avg Return
Past Year
Past Year
27%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
83.3%
Neutral
11.1%
Negative
5.6%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Maintained
| $1,091 |
36%
upside
| 2 | +11% |
0
%
| 8 Jan ‘26 10 days ago |
|
|
|
Neutral
Downgraded
| $14.50 |
1%
upside
| 2 | +30% |
0
%
| 22 Dec ‘25 27 days ago |
|
|
|
Buy
Initiated
| $64 |
93%
upside
| 1 | +0.82% |
0
%
| 17 Dec ‘25 1 month ago |
|
|
|
Buy
Maintained
| $30 |
120%
upside
| 1 | +57% |
0
%
| 9 Dec ‘25 1 month ago |
|
|
|
Buy
Maintained
| $100 |
13%
upside
| 1 | +91% |
0
%
| 9 Dec ‘25 1 month ago |
|
|
|
Buy
Initiated
| $102 |
171%
upside
| 1 | -38% |
0
%
| 26 Nov ‘25 1 month ago |
|
|
|
Buy
Initiated
| $38 |
40%
upside
| 1 | -4.4% |
0
%
| 26 Nov ‘25 1 month ago |
|
|
|
Buy
Initiated
| $136 |
34%
upside
| 1 | -4.6% |
0
%
| 25 Nov ‘25 1 month ago |
|
|
|
Buy
Maintained
| $14 |
7%
upside
| 1 | +12% |
0
%
| 13 Nov ‘25 2 months ago |
|
|
|
Neutral
Maintained
| $4.25 |
7%
upside
| 1 | – |
–
| 11 Nov ‘25 2 months ago |
|
|
|
Buy
Maintained
| $26 |
12%
upside
| 2 | +26% |
0
%
| 11 Nov ‘25 2 months ago |
|
|
|
Buy
Maintained
| $33 |
45%
upside
| 1 | +8.1% |
0
%
| 7 Nov ‘25 2 months ago |
|
|
|
Buy
Maintained
| $15 |
26%
downside
| 2 | +102% |
0
%
| 29 Oct ‘25 2 months ago |
|
|
|
Sell
Downgraded
| $5 |
70%
downside
| 1 | -71% |
0
%
| 29 Oct ‘25 2 months ago |
|